Diabetes News and Research

Latest Diabetes News and Research

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today it has in-licensed BL-1110, a novel compound for the treatment of neuropathic pain.

23 Jun 2014

First Edition: June 23, 2014

Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.

23 Jun 2014

Study reveals that inflammasomes remain active even after cell death

Even after a cell dies, components of the immune system remain active and continue to fuel inflammatory reactions.

23 Jun 2014

Experts from 96 countries gather in Chicago to attend ICE/ENDO 2014

ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society, has tallied more registrants than any other annual meeting in the Endocrine Society's nearly 100-year history.

23 Jun 2014

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.

23 Jun 2014

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

This report estimated the effect of the Affordable Care Act (ACA) on 14 large and diverse cities: Los Angeles, Chicago, Houston, Philadelphia, Phoenix, Indianapolis, Columbus, Charlotte, Detroit, Memphis, Seattle, Denver, Atlanta, and Miami.

21 Jun 2014

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration approved SIVEXTRO (tedizolid phosphate) for the treatment of adult acute bacterial skin and skin structure infections (ABSSSI).

21 Jun 2014

Greenlander study identifies single mutation with large diabetes risk

Researchers have used a Greenlandic cohort to identify a genetic mutation whose effect on the risk of diabetes is “several times larger” than any previously discovered.

20 Jun 2014

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes.

20 Jun 2014

NIH receives $10 million grant for research on breast cancer metastasis

The American Cancer Society predicts that 40,000 American women will die from breast cancer this year. Most of those deaths will occur due to cells from the primary tumor that spread to other parts of the body-the process known as metastasis.

20 Jun 2014

Osteoarthritis may be treated with stem cell mobilization therapy

Researchers in Taiwan have found that peripheral blood stem cells can be "mobilized" by injection of a special preparation of granulocyte colony-stimulating factor (G-CSF) into rats that modeled osteoarthritis (OA).

20 Jun 2014

New research reveals gene's role in type 1 diabetes

New research describes details of how a diabetes-related gene functions on a biological pathway that affects the release of insulin. The study authors say that finding drugs that act on that pathway may eventually lead to a new treatment for type 1 diabetes.

20 Jun 2014

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania found that a susceptibility gene for type 1 diabetes regulates self-destruction of the cell's energy factory. They report their findings this week in Cell.

20 Jun 2014

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

Melanoma in adulthood can be reduced by consistent use of sunscreen in childhood

Research conducted at the Texas Biomedical Research Institute, published in the latest issue of the scientific journal Pigment Cell and Melanoma, has established unequivocally in a natural animal model that the incidence of malignant melanoma in adulthood can be dramatically reduced by the consistent use of sunscreen in infancy and childhood.

20 Jun 2014

Experts urge business to track worker health

A new group is urging businesses to improve the health of employees -- and says the move could save up to $30 billion a year in health care costs.

20 Jun 2014

First Edition: June 19, 2014

Today's headlines include reports about how the 2015 insurance premium rates are shaping up across the country and details of consumers' experiences in trying to get their new coverage.

19 Jun 2014

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

A spectacular piece of detective work has mapped a special gene variant among Greenlanders which plays a particularly important role in the development of type 2 diabetes.

19 Jun 2014

Study of SLC13 transporters unlocks their therapeutic potential

Researchers have provided the first functional analysis of a member of a family of transporter proteins implicated in diabetes, obesity, and lifespan. The study appears in the June issue of The Journal of General Physiology.

19 Jun 2014

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Alexian Brothers Health System is suspending its effort to launch a new Medicaid program, blaming the difficulty of connecting physicians using different electronic records systems. The Arlington Heights, Ill.-based health system was spearheading a so-called accountable care entity (ACE) to coordinate the care of about 46,000 patients on Medicaid, the state-federal health insurance program for the poor and disabled. The ACEs are a form of managed care, one of Gov. Pat Quinn's initiatives to focus on preventative treatment to keep patients healthy and reduce health care costs (Schorsch, 6/17).

19 Jun 2014

Diabetes News and Research

Latest Diabetes News and Research

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

First Edition: June 23, 2014

Study reveals that inflammasomes remain active even after cell death

Experts from 96 countries gather in Chicago to attend ICE/ENDO 2014

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Greenlander study identifies single mutation with large diabetes risk

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

NIH receives $10 million grant for research on breast cancer metastasis

Osteoarthritis may be treated with stem cell mobilization therapy

New research reveals gene's role in type 1 diabetes

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

New driver of atherosclerosis may prove to be promising therapeutic target

Melanoma in adulthood can be reduced by consistent use of sunscreen in childhood

Experts urge business to track worker health

First Edition: June 19, 2014

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

Study of SLC13 transporters unlocks their therapeutic potential

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in